Cargando…

Regadenoson stress induced wall motion abnormalities during cardiac MRI

Detalles Bibliográficos
Autores principales:	Parikh, Kalindi, Bandettini, Patricia W, Chen, Marcus Y, Yu, Jeannie H, Shanbhag, Sujata M, Arai, Andrew E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328357/ http://dx.doi.org/10.1186/1532-429X-17-S1-P96

Ejemplares similares

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Initial description of changes in wall motion parameters in normal subjects undergoing rest/regadenoson stress using a tagged MRI sequence
por: Soltys, Joseph S, et al.
Publicado: (2016)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Feasibility and results of acute cardiac stress MRI with regadenoson for risk stratification of COPD-patients with NSTEMI
por: Range, Felix T, et al.
Publicado: (2015)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Real time cardiac MRI and its clinical usefulness in arrhythmias and wall motion abnormalities
por: Unterberg-Buchwald, Christina, et al.
Publicado: (2014)

Characterization of cardiac masses with T1 mapping
por: Saba, Shahryar G, et al.
Publicado: (2015)

Risk stratification by regadenoson stress MRI in patients with known or suspected coronary artery disease
por: Abbasi, Siddique A, et al.
Publicado: (2014)

High prevalence of atypical delayed enhancement in alkaptonuria
por: Chen, Marcus Y, et al.
Publicado: (2014)

Feasibility of detecting myocardial ischemia using first-pass contrast MRI and regadenoson
por: Lyons, Matthew, et al.
Publicado: (2012)

Image quality and diagnostic accuracy of inline motion-corrected (moco) first-pass stress myocardial perfusion images
por: Shanbhag, Sujata M, et al.
Publicado: (2011)

Acute regadenoson stress prefusion testing using cardiac MRI is a valuable test of high predictive value for risk stratification of COPD-patients with NSTEM
por: Range, Felix T, et al.
Publicado: (2016)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

Clinical impact of cardiovascular magnetic resonance in evaluation for possible arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Choi, Andrew D, et al.
Publicado: (2015)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Regional wall motion abnormalities at rest and stress in patients with end-stage renal disease diagnosed by cardiac magnetic resonance imaging
por: Merten, Constanze, et al.
Publicado: (2009)

Interobserver reproducibility of fully quantitative pixel-wise analysis of clinical CMR perfusion imaging
por: Conn, Hannah, et al.
Publicado: (2014)

Cardiac magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress
por: Schuster, Andreas, et al.
Publicado: (2012)

In the absence of obstructive coronary artery disease, patients with class II and III obesity have decreased myocardial perfusion reserve
por: Bandettini, W Patricia, et al.
Publicado: (2014)

Right ventricular wall motion abnormalities n Thalassemia Major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Regadenoson as a pharmacologic stressor in cardiac magnetic resonance imaging in congenital and acquired pediatric heart disease: initial experience
por: Noel, Cory V, et al.
Publicado: (2015)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Association of reduced right ventricular global and regional wall motion with abnormal right heart hemodynamics
por: Muthukumar, Lakshmi, et al.
Publicado: (2015)

Concordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA
por: Chen, Marcus Y., et al.
Publicado: (2013)

Rapid 4D regional wall motion characterization of abdominal aortic aneurysms with intra-luminal thrombus using cine cardiac MRI
por: Menon, Prahlad G, et al.
Publicado: (2014)

Wall motion recovery in dobutamine stress magnetic resonance imaging
por: Berger, Alexander, et al.
Publicado: (2011)

Using mDixon to remove motion artifacts in carotid artery vessel wall MRI
por: Wang, Jinnan, et al.
Publicado: (2012)

Clinical evaluation of inline motion correction for cardiac perfusion MRI
por: Kino, Aya, et al.
Publicado: (2011)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Cardiovascular magnetic resonance myocardial feature tracking predicts severity of wall motion abnormalities following acute coronary syndromes
por: De Silva, Kalpa, et al.
Publicado: (2013)

Extent of wall motion abnormalities with cardiovascular magnetic resonance imaging overestimates the degree of coronary artery disease in patients with ischemic cardiomyopathy
por: Danilov, Tatyana, et al.
Publicado: (2011)

Stress perfusion cardiac MRI in women
por: h-Ici, Darach O, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cu425la9lk4q0mvse6j0a64ecc